Clinical-stage development companies

Companies whose enriched business profile is tagged “Clinical-stage development”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.

• RELAY THERAPEUTICS INC (RLAY) Health Care — Early-stage biotech leveraging structure-based drug design to develop small-molecule therapeutics addressing oncology and other diseases. ask →
• ANAPTYSBIO INC (ANAB) Health Care — AnaptysBio is an immunotherapy company generating revenue from blockbuster royalties (Jemperli with GSK, imsidolimab with Vanda) while pursuing its own clinical-stage pipeline for autoimmune and inflammatory diseases. ask →
• AVALYN PHARMA INC (AVLN) Health Care — Early-stage biopharmaceutical company developing novel therapeutic candidates across multiple disease indications. ask →
• VOR BIOPHARMA INC (VOR) Health Care — Vor Biopharma is a clinical-stage biopharmaceutical company developing advanced cell therapy and gene therapy solutions for blood disorders and cancers. ask →
• TENAX THERAPEUTICS INC (TENX) Health Care — A Phase 3 development-stage pharmaceutical company developing novel cardiopulmonary therapies, primarily levosimendan for pulmonary hypertension and imatinib for pulmonary arterial hypertension. ask →
• EVOMMUNE INC (EVMN) Health Care — Evommune is an immunology-focused clinical-stage biotech developing novel product candidates EVO756 and EVO301 to address unmet disease needs. ask →
• LINEAGE CELL THERAPEUTICS INC (LCTX) Health Care — Lineage Cell Therapeutics develops allogeneic cell therapy treatments for serious human diseases through its AlloSCOPE™ manufacturing platform and partnerships with major pharmaceutical companies. ask →
• FULCRUM THERAPEUTICS INC (FULC) Health Care — Fulcrum Therapeutics discovers and develops treatments for genetically-defined rare diseases, with pociredir as a lead clinical-stage program. ask →
• TRISALUS LF SC CM A (TLSI) Health Care — TriSalus is a clinical-stage biopharma and commercial medical device company developing immunotherapies and pressure-enabled drug delivery systems. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-07-10.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.